| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-194 |
Sentence |
denotes |
Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models. |
| T1 |
0-194 |
Sentence |
denotes |
Limited involvement of interleukin-6 in the pathogenesis of lethal septic shock as revealed by the effect of monoclonal antibodies against interleukin-6 or its receptor in various murine models. |
| T2 |
195-397 |
Sentence |
denotes |
Several studies in human patients and in laboratory animals have revealed a correlation between serum interleukin (IL)-6 levels and outcome in clinical sepsis and in related animal models, respectively. |
| T2 |
195-397 |
Sentence |
denotes |
Several studies in human patients and in laboratory animals have revealed a correlation between serum interleukin (IL)-6 levels and outcome in clinical sepsis and in related animal models, respectively. |
| T3 |
398-588 |
Sentence |
denotes |
In the present study, two monoclonal antibodies were used to investigate the contribution of IL-6 in the lethal action of tumor necrosis factor (TNF) and of lipopolysaccharide (LPS) in mice. |
| T3 |
398-588 |
Sentence |
denotes |
In the present study, two monoclonal antibodies were used to investigate the contribution of IL-6 in the lethal action of tumor necrosis factor (TNF) and of lipopolysaccharide (LPS) in mice. |
| T4 |
589-711 |
Sentence |
denotes |
We studied the potential protective properties of an anti-murine (m) IL-6 antibody and of an anti-mIL-6 receptor antibody. |
| T4 |
589-711 |
Sentence |
denotes |
We studied the potential protective properties of an anti-murine (m) IL-6 antibody and of an anti-mIL-6 receptor antibody. |
| T5 |
712-846 |
Sentence |
denotes |
In controlled experiments, we observed that both monoclonal antibodies conferred a dose-dependent protection to a lethal dose of mTNF. |
| T5 |
712-846 |
Sentence |
denotes |
In controlled experiments, we observed that both monoclonal antibodies conferred a dose-dependent protection to a lethal dose of mTNF. |
| T6 |
847-1013 |
Sentence |
denotes |
Detailed studies with the monoclonal antibodies indicate, however, that protection was no longer observed when the mTNF dose was slightly higher than the lethal dose. |
| T6 |
847-1013 |
Sentence |
denotes |
Detailed studies with the monoclonal antibodies indicate, however, that protection was no longer observed when the mTNF dose was slightly higher than the lethal dose. |
| T7 |
1014-1185 |
Sentence |
denotes |
Likewise, the anti-IL-6 monoclonal antibody protected against injections of LPS at a lethal-dose concentration, but here too failed to protect against higher doses of LPS. |
| T7 |
1014-1185 |
Sentence |
denotes |
Likewise, the anti-IL-6 monoclonal antibody protected against injections of LPS at a lethal-dose concentration, but here too failed to protect against higher doses of LPS. |
| T8 |
1186-1357 |
Sentence |
denotes |
The anti-IL-6 monoclonal antibody was unable to protect against mTNF in mice sensitized by galactosamine, the corticoid receptor antagonist RU38486 or human (h) IL-1 beta. |
| T8 |
1186-1357 |
Sentence |
denotes |
The anti-IL-6 monoclonal antibody was unable to protect against mTNF in mice sensitized by galactosamine, the corticoid receptor antagonist RU38486 or human (h) IL-1 beta. |
| T9 |
1358-1425 |
Sentence |
denotes |
Protection did not correlate with the serum concentrations of IL-6. |
| T9 |
1358-1425 |
Sentence |
denotes |
Protection did not correlate with the serum concentrations of IL-6. |
| T10 |
1426-1523 |
Sentence |
denotes |
Finally, we demonstrate that hIL-6 injection did not change the sensitivity of mice towards mTNF. |
| T10 |
1426-1523 |
Sentence |
denotes |
Finally, we demonstrate that hIL-6 injection did not change the sensitivity of mice towards mTNF. |
| T11 |
1524-1703 |
Sentence |
denotes |
We conclude that, although IL-6 levels may be of value as a marker for the outcome in septic shock, this cytokine contributes only marginally in the pathogenesis leading to death. |
| T11 |
1524-1703 |
Sentence |
denotes |
We conclude that, although IL-6 levels may be of value as a marker for the outcome in septic shock, this cytokine contributes only marginally in the pathogenesis leading to death. |
| T12 |
1704-1835 |
Sentence |
denotes |
The small, but real, contribution of IL-6 in some situations might be due to its ability to up-regulate the level of TNF receptors. |
| T12 |
1704-1835 |
Sentence |
denotes |
The small, but real, contribution of IL-6 in some situations might be due to its ability to up-regulate the level of TNF receptors. |